 BioSig Technologies, Inc. NASDAQ:BSGM said it has entered into three new evaluation agreements for the PURE EP System, its novel electrophysiology EP signal acquisition and analysis technology. The group said new clinical sites due to receive BioSigs PURE EP System include New York-PresbyterianWeill Cornell Medical Center, Michigan MedicineUniversity Hospital - two centers that account for two of the largest EP programs in the country - and Houston Methodist Hospital. 